Greenwich Rx recalls compounded glutathione nationwide over endotoxin levels

Greenwich Rx is voluntarily recalling specific lots of its compounded glutathione nationwide because of potential elevated endotoxin levels, according to the company’s announcement posted by the FDA. The recall covers glutathione 200 mg/mL in 10mL multidose vials intended for subcutaneous injection. The product was distributed to patients nationwide between June 26, 2026, and September 21, 2026.

Greenwich Rx said injectable products with elevated endotoxin levels could cause fevers, hypotension, inflammatory reactions, anaphylactic shock and death. The company has received two reports involving patients who received emergency department care after intravenous administration of a glutathione product that was not formulated for IV use.

Greenwich Rx is notifying customers by mail. People who received product from a recalled lot should stop using it and follow the disposal instructions in the notice. The company said patients who believe they experienced a related health issue should contact a healthcare provider.